Experience of malignancies with oral glucose-lowering drugs in the randomised controlled ADOPT (A Diabetes Outcome Progression Trial) and RECORD (Rosiglitazone Evaluated for Cardiovascular Outcomes and Regulation of Glycaemia in Diabetes) clinical t (Q34023560)
scientific article
Language:
Current Data About Experience of malignancies with oral glucose-lowering drugs in the randomised controlled ADOPT (A Diabetes Outcome Progression Trial) and RECORD (Rosiglitazone Evaluated for Cardiovascular Outcomes and Regulation of Glycaemia in Diabetes) clinical t
(P31) (Q13442814)
(P248)
(P932) 2910882
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20532476%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, February 5, 2020

(P50) (Q41640212)
(P1545) 2
(P248)
(P932) 2910882
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20532476%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, February 5, 2020

(P304) 1838-1845
(P248)
(P932) 2910882
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20532476%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, February 5, 2020

(P433) 9
(P248)
(P932) 2910882
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20532476%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, February 5, 2020

(P478) 53
(P248)
(P932) 2910882
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20532476%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, February 5, 2020

(P577) Tuesday, June 8, 2010
(P248)
(P932) 2910882
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20532476%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, February 5, 2020

(P921) (Q11068)
(P887)

(Q424771)
(P887)

(P1433) (Q5270140)
(P248)
(P932) 2910882
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20532476%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, February 5, 2020

(P1476) "Experience of malignancies with oral glucose-lowering drugs in the randomised controlled ADOPT (A Diabetes Outcome Progression Trial) and RECORD (Rosiglitazone Evaluated for Cardiovascular Outcomes and Regulation of Glycaemia in Diabetes) clinical trials" (language: en)
(P248)
(P932) 2910882
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20532476%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, February 5, 2020

(P2093) P D Home
(P1545) 1
(P248)
(P932) 2910882
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20532476%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, February 5, 2020

N P Jones
(P1545) 3
(P248)
(P932) 2910882
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20532476%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, February 5, 2020

D Noronha
(P1545) 4
(P248)
(P932) 2910882
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20532476%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, February 5, 2020

H Beck-Nielsen
(P1545) 5
(P248)
(P932) 2910882
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20532476%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, February 5, 2020

G Viberti
(P1545) 6
(P248)
(P932) 2910882
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20532476%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, February 5, 2020

ADOPT Study Group
(P1545) 7
(P248)
(P932) 2910882
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20532476%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, February 5, 2020

RECORD Steering Committee
(P1545) 8
(P248)
(P932) 2910882
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20532476%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, February 5, 2020

(P2860) (Q34985342)
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910882
(P813) Saturday, July 28, 2018

(Q36820202)
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910882
(P813) Saturday, July 28, 2018

(Q40216291)
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910882
(P813) Saturday, July 28, 2018

(Q29616275)
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910882
(P813) Saturday, July 28, 2018

(Q33649238)
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910882
(P813) Saturday, July 28, 2018

(Q29547282)
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910882
(P813) Saturday, July 28, 2018

(Q27860882)
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910882
(P813) Saturday, July 28, 2018

(Q54732953)
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910882
(P813) Monday, October 29, 2018

(Q34609508)
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910882
(P813) Monday, October 29, 2018

(Q29620534)
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910882
(P813) Monday, October 29, 2018

(Q46917157)
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910882
(P813) Monday, October 29, 2018

(Q44001864)
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910882
(P813) Monday, October 29, 2018

other details